直 Japanese PDF Font
  • 弁護士等
  • 業務内容
  • 論文等
  • オフィス
  • 事務所概要
  • 採用情報
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • CAFC控訴審関連ブログ
    • INCONTESTABLE® Blog
    • 出願関連ブログ
  • Events & Webinars
  • 知財最新ニュース
  • ポッドキャスト
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Lecture

2013 Pharmaceutical Intellectual Property Forum

November 27-28, 2013

Shanghai, China

UBM International Media

Finnegan is a sponsor of the 2013 Pharmaceutical Intellectual Property Forum. Finnegan partner Ningling Wang will present "The Value of U.S. Patents" and "Biologics Price Competition and Innovation Act." The conference will bring together pharmaceutical industry practitioners and executives to meet and discuss business opportunities. The event will take place in Shanghai, China.

Related Practices

特許出願及びポートフォリオ管理

Related Industries

Biologics

Biotechnology

製薬

Related Offices

Shanghai

Related Professionals

Ningling Wang
Partner
Shanghai
+86 21 6194 2005
Email

Related Insights

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Hybrid Conference

Intellectual Property Law Institute 2026 – California

October 19-20, 2026

San Francisco

Hybrid Conference

Intellectual Property Law Institute 2026 – New York

September 28-29, 2026

New York

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Seminar

IAM and WTR Live: Australasia IP Forum 2026

August 11, 2026

Melbourne

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Conference

2026 China Pharmaceutical Innovation Conference

July 22-24, 2026

Shanghai

Federal Circuit IP Blog

“2” Does Not Provide Written Description Support for “1”: Federal Circuit Affirms District Court’s Invalidation of Patent

July 8, 2026

Federal Circuit IP Blog

Federal Circuit Affirms Noninfringement Ruling in Hatch-Waxman Litigation Based on Claim Construction, Prosecution History Estoppel, and the Disclosure-Dedication Rule

June 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • プライバシー
  • 免責事項
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP